April 11 2022NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through international clinical research, recently created a Veterans Affairs/Military Treatment Facility (VA-MTF) Subcommittee to provide a forum for advocating for these communities and engaging them in NRG…
March 31 2023Combined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trials…
February 03 2023NRG Oncology Phase III clinical trial, NRG-GY018, evaluating pembrolizumab in combination with standard of care chemotherapy (carboplatin and paclitaxel) met its primary endpoint…
Sinus infections are very common; they affect an estimated one in eight adults each year….
Are you a man between the ages of 50 and 64? You may qualify for a free cancer screening, not yet available to the general…
Today, medical experts join us to help send the message that life after cancer is something worth celebrating, and a better quality of life for…
April 11 2022NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through international…
Federal Practitioner is a monthly, peer-reviewed clinical journal for clinicians in the Department of Veterans Affairs, Department of Defense, and Public
Oropharyngeal squamous cell carcinoma (OPSCC), largely fueled by the human papillomavirus (HPV), has a complex biological and immunologic phenotype. Although HPV/p16 status can be used…
